Chidamide-based 3-drug combination regimen reverses molecular relapse post transplantation in AML1-ETO–positive acute myeloid leukemia

Objective: We aimed to explore a new method to reverse early relapse in patients with AML1-ETO–positive acute myeloid cell transplantation. Methods: A chidamide-based 3-drug combination regimen was used in our center to treat patients with AML1-ETO–positive AML post transplantation but negative flow...

Descripción completa

Detalles Bibliográficos
Autores principales: Xi, Yang, Chenglong, Li, Rong, Zhang, Wen, Wang, Yu, Wang, Jiao, Chen, Juan, Huang, Feifei, Che, Rong, Xiao, Tao, Jiang, Hui, Li, Xiaobing, Huang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880285/
https://www.ncbi.nlm.nih.gov/pubmed/36712661
http://dx.doi.org/10.3389/fphar.2022.1059930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880285/
https://www.ncbi.nlm.nih.gov/pubmed/36712661
http://dx.doi.org/10.3389/fphar.2022.1059930

Ejemplares similares